3,4,5-Trimethoxycinnamic acid
3,4,5-Trimethoxycinnamic acid (O-Methylsinapic acid, TMCA), a component of Polygalae Radix, is a research chemical with potential anticonvulsant properties. Studies suggest its activity may involve modulation of the GABAA/benzodiazepine receptor complex, supporting its use in neuroscience research for seizure-related in vitro and in vivo investigations.
Product Specifications
CAS Number
90-50-6
Product Name Alternative
γ-Aminobutyric acid Receptor, Inhibitor, EndogenousMetabolite, Endogenous Metabolite, GABAR, GABAReceptor, GABA Receptor, Gamma-aminobutyric acid Receptor, inhibit, O-Methylsinapic acid, 3,4,5Trimethoxycinnamic acid, 3,4,5-Trimethoxycinnamic acid, 3,4,5 Trimethoxycinnamic acid, 3- (3,4,5-Trimethoxyphenyl) acrylic Acid
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
98.91% (May vary between batches)
Solubility
DMSO:45 mg/mL (188.89 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.39 mM)
Smiles
O=C (O) C=CC1=CC (OC) =C (OC) C (OC) =C1
Molecular Formula
C12H14O5
Molecular Weight
238.24
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1091647-01 0.02 mg (E-Coli)
Recombinant Vaccinia virus Complement control protein (C3L)
Sign In for Pricing
View Details MBS1091647-02 0.1 mg (E-Coli)
Recombinant Vaccinia virus Complement control protein (C3L)
Sign In for Pricing
View Details MBS1091647-03 0.02 mg (Yeast)
Recombinant Vaccinia virus Complement control protein (C3L)
Sign In for Pricing
View Details MBS1091647-04 0.1 mg (Yeast)
Recombinant Vaccinia virus Complement control protein (C3L)
Sign In for Pricing
View Details